Global Veterinary Endocrinology Market Introduction and Overview
According to SPER Market Research, the Global Veterinary Endocrinology Market is estimated to reach USD 602.96 million by 2033 with a CAGR of 7.08%.
The report includes an in-depth analysis of the Global Veterinary Endocrinology Market, including market size and trends, product mix, applications, and supplier analysis. The field of veterinary medicine known as veterinary endocrinology is dedicated to the investigation, diagnosis, and management of problems involving hormones in animals. This discipline focuses on comprehending the endocrine system, which is made up of glands including the pituitary, thyroid, adrenal glands, and pancreas. These glands create hormones that control a number of body processes, including growth, metabolism, reproduction, and stress reactions. In animals, veterinary endocrinologists identify conditions such as diabetes mellitus, Cushing's disease, Addison's disease, hypothyroidism, and hyperthyroidism.
- A new endocrinology app based on machine learning, a type of artificial intelligence, was developed and released in October 2023 by Royal Veterinary College (RVC) and Dechra in the UK to assist veterinarians in diagnosing and treating endocrine diseases in pets.
- The FDA approved Elanco's Bexacat, the first oral drug for managing diabetes in cats, in December 2022. This increased the company's selection of feline items.
Market Opportunities and Challenges
Opportunities- The main factors propelling the market's expansion are the growing medicalization rate, disease prevalence, pet insurance adoption, pet humanization, and R&D and other strategic activities by major corporations. The FDA approved Senvelgo, the first liquid oral medication for glycemic management in cats with diabetes mellitus, in August 2023, according to Boehringer Ingelheim. The company's portfolio was enlarged as a result. Another factor propelling the market is the growing R&D activities of top businesses that concentrate on important endocrine diseases in animals. The development of novel diagnostic and treatment techniques by major businesses like Dechra and Boehringer Ingelheim is driving this expansion. Pets' growing endocrine conditions, including diabetes, Cushing's disease, Addison's disease, and thyroid issues, are a major factor propelling the market's expansion.
Challenges- The growth and development of the worldwide veterinary endocrinology market are impacted by a number of obstacles. One significant issue is pet owners' ignorance of endocrine diseases, which frequently results in delayed diagnosis and treatment. Furthermore, there is a dearth of qualified experts in veterinary endocrinology, especially in underprivileged areas, due to the specialty knowledge and training needed for this sector. Accessibility for pet owners may also be hampered by the high expense of hormone-related disease diagnostics, therapies, and prescription drugs, particularly in low-income communities.
Market Competitive Landscape
The Global Veterinary Endocrinology Market is moderately consolidated. Some of the market key players are Dechra Pharmaceuticals PLC; Boehringer Ingelheim; Elanco; Merck & Co., Inc.; Zoetis; LLOYD, Inc.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Animal Type, By Application, By Route of Administration |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Dechra Pharmaceuticals PLC; Boehringer Ingelheim; Elanco; Merck & Co., Inc.; Zoetis; LLOYD, Inc. |
COVID-19 Impact on Global Veterinary Endocrinology Market
The global market for veterinary endocrinology has been significantly impacted by the COVID-19 epidemic, both directly and indirectly. Many hospitals and veterinary clinics experienced interruptions during the pandemic as a result of social distancing measures, lockdowns, and a decrease in non-emergency procedures. Delays in diagnosing and treating hormone-related illnesses in animals resulted from a decrease in veterinarian consultations, especially those for endocrine-related conditions.
On the supply side, the pandemic led to shortages and higher prices by delaying the manufacture and delivery of veterinary drugs, diagnostic equipment, and supplies. Disruptions to the global supply chain also affected the availability of necessary medications for treating diseases including diabetes and thyroid issues in animals.
Key Target Audience:
- Veterinarians and Veterinary Clinics
- Pet Owners
- Pharmaceutical Companies
- Animal Health Organizations
- Research Institutions and Universities
- Animal Hospitals and Specialized Endocrinology Centers
Our in-depth analysis of the Global Veterinary Endocrinology Market includes the following segments:
| By Animal Type: | DogsCatsOther Animals |
| By Application: | Pancreatic DisordersOther Disorders |
| By Route of Administration: | Pancreatic OralOther Routes DisordersOther Disorders |
Key Topics Covered in the Report:
- Global Veterinary Endocrinology Market Size (FY’2024-FY’2033)
- Overview of Global Veterinary Endocrinology Market
- Segmentation of Global Veterinary Endocrinology Market By Animal Type (Dogs, Cats, Other Animals)
- Segmentation of Global Veterinary Endocrinology Market By Application (Pancreatic, Disorders, Other Disorders)
- Segmentation of Global Veterinary Endocrinology Market By Route of Administration (Pancreatic Oral, Other Routes Disorders, Other Disorders)
- Statistical Snap of Global Veterinary Endocrinology Market
- Expansion Analysis of Global Veterinary Endocrinology Market
- Problems and Obstacles in Global Veterinary Endocrinology Market
- Competitive Landscape in the Global Veterinary Endocrinology Market
- Impact of COVID-19 and Demonetization on Global Veterinary Endocrinology Market
- Details on Current Investment in Global Veterinary Endocrinology Market
- Competitive Analysis of Global Veterinary Endocrinology Market
- Prominent Players in the Global Veterinary Endocrinology Market
- SWOT Analysis of Global Veterinary Endocrinology Market
- Global Veterinary Endocrinology Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Veterinary Endocrinology Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Veterinary Endocrinology Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Veterinary Endocrinology Market
7. Global Veterinary Endocrinology Market, By Animal Type (USD Million) 2020-2033
7.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Animal Type, 2020-2026
7.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Animal Type, 2027-2033
7.3. Dogs
7.4. Cats
7.5. Other Animals
8. Global Veterinary Endocrinology Market, By Application (USD Million) 2020-2033
8.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Application, 2020-2026
8.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Application, 2027-2033
8.3. Pancreatic Disorders
8.4. Other Disorders
9. Global Veterinary Endocrinology Market, By Route of Administration (USD Million) 2020-2033
9.1. Global Veterinary Endocrinology Market Size, Share and Forecast, By Route of Administration, 2020-2026
9.2. Global Veterinary Endocrinology Market Size, Share and Forecast, By Route of Administration, 2027-2033
9.3. Pancreatic Oral
9.4. Other Routes Disorders
9.5. Other Disorders
10. Global Veterinary Endocrinology Market Forecast, 2020-2033 (USD Million)
10.1. Global Veterinary Endocrinology Market Size and Market Share
11. Global Veterinary Endocrinology Market, By Region, 2020-2033 (USD Million)
11.1. Global Veterinary Endocrinology Market Size and Market Share By Region (2020-2026)
11.2. Global Veterinary Endocrinology Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Dechra Pharmaceuticals PLC
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Elanco
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Merck & Co., Inc.
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Boehringer Ingelheim
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. ZoetisL
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. LLOYD, Inc.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links